Lumito AB (publ) (NGM:LUMITO)

Market Cap	25.57M -79.4%
Revenue (ttm)	81.51K +379.4%
Net Income	-48.06M
EPS	-91.90
Shares Out	3.44M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	10,969
Average Volume	16,851
Open	n/a
Previous Close	6.48
Day's Range	n/a
52-Week Range	6.46 - 348.50
Beta	0.72
RSI	44.84
Earnings Date	Feb 20, 2026

About Lumito AB

Lumito AB (publ) engages in the medical research and development of imaging technology in Sweden. It offers tissue analysis system based on upconverting nanoparticles, including SCIZYS system combining labeling and imaging technologies to locate and measure biomarkers in tissue samples. The company’s technology addresses challenges in various application areas, such as drug development, academic research, and clinical diagnostics. Lumito AB (publ) was incorporated in 2010 and is headquartered in Lund, Sweden.

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 2010
• Employees: 11
• Stock Exchange: Nordic Growth Market
• Ticker Symbol: LUMITO